Preventing end-stage renal disease: The potential impact of screening and intervention in developing countries

Nephrology Dialysis Transplantation

Volumn 18, Issue 5, 2003, Pages 858-859

  Schieppati, Arrigo ^a,b   Perico, Norberto ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Developing countries; End stage renal disease; Renal replacement therapy; Screening

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC TEST; DIALYSIS; ECONOMIC ASPECT; EDITORIAL; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH EDUCATION; HEALTH PROGRAM; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFESTYLE; MEDICAL RESEARCH; PATENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; SCREENING TEST;

DEVELOPING COUNTRIES; HUMANS; INTERNATIONAL AGENCIES; KIDNEY FAILURE, CHRONIC; MASS SCREENING; RENAL REPLACEMENT THERAPY;

EID: 0037687798     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg166     Document Type: Editorial

References (13)

1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13: S37-S40
2. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14 [Suppl 6]: 31-41
3. Rutkowski B, Ciocalteu A, Djukanovic L et al. Evolution of renal replacement therapy in Central and Eastern Europe 7 years after political and economical liberation. Central and Eastern Europe Advisory Board in Chronic Renal Failure. Nephrol Dial Transplant 1998; 13: 860-864
4. Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999; 14: 2332-2342
5. US Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002
6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753
7. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608
8. Mani MK. Clinical and epidemiologica programme on renal disease. Nephrol Dial Transplant 1999; 14: 1807-1808
9. Plata R, Silva C, Yahuita J, Perez L, Schieppati A, Remuzzi G. The first clinical epidemiologica programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in developing countries. Nephrol Dial Transplant 1998; 13: 3034-3036
10. Hoy W. Reflections on the XVth ICN Meeting: renal and cardiovascular protection in the developing world. Nephrol Dial Transplant 2001; 16: 1509-1511
11. Hoy WE, Baker PRA, Kelly AM, Wang Z. Reducing premature death and renal failure in Australian Aborigines: results of a community-based cardiovascular and renal-protective program. Med J Aus 2000; 172: 473-478
12. Schieppati A, Garattini S, Remuzzi G. Modulating the profit motive to meet needs of the less-developed world. Lancet 2001; 358: 1638-1641
13. Time to make the Global Fund global. Lancet 2002; 360: 181